BuzBuz Capital Corp. Provides Further Details on Its Proposed Qualifying Transaction with Inolife R&D Inc.
BUZ or the
Inolife ) have entered into a definitive business combination agreement dated October 1, 2020 (the
Agreement ) whereby BUZ will acquire all of the securities of Inolife by way of a three-cornered amalgamation (the
Transaction ), to form the resulting issuer (the
Resulting Issuer ).
Proposed Management of the Resulting Issuer
Upon completion of the proposed Transaction, the board of directors of the Resulting Issuer is expected to be comprised of Michael Wright, Derek Lindsay, Karen Dunlap, John Leumbruno and William Cleman.
Upon completion of the proposed Transaction, all existing officers of the Corporation shall resign and be replaced with officers appointed by the new board of directors. The following sets out the names and backgrounds of all persons who are expected to be directors, officers and insiders of the Resulting Issuer as the case may be